Sandra Rebouissou
Overview
Explore the profile of Sandra Rebouissou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
4346
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hernandez C, Verzeroli C, Roca-Suarez A, Farca-Luna A, Tonon L, Esteban-Fabro R, et al.
JHEP Rep
. 2024 Dec;
7(1):101245.
PMID: 39717507
Background & Aims: Owing to unexplained interpatient variation and treatment failure in hepatocellular carcinoma (HCC), novel therapeutic approaches remain an urgent clinical need. Hepatic neurons, belonging to the autonomic nervous...
2.
Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments
Campani C, Imbeaud S, Couchy G, Ziol M, Hirsch T, Rebouissou S, et al.
Gut
. 2024 Jul;
73(11):1870-1882.
PMID: 39054058
Objective: Circulating tumour DNA (ctDNA) is a promising non-invasive biomarker in cancer. We aim to assess the dynamic of ctDNA in patients with hepatocellular carcinoma (HCC). Design: We analysed 772...
3.
Pire A, Hirsch T, Morcrette G, Imbeaud S, Gupta B, Pilet J, et al.
Eur J Cancer
. 2024 Feb;
200:113583.
PMID: 38330765
Background: Hepatoblastoma is the most frequent pediatric liver cancer. The current treatments lead to 80% of survival rate at 5 years. In this study, we evaluated the clinical relevance of...
4.
Pilet J, Hirsch T, Gupta B, Roehrig A, Morcrette G, Pire A, et al.
Nat Commun
. 2023 Nov;
14(1):7122.
PMID: 37932266
Pediatric liver tumors are very rare tumors with the most common diagnosis being hepatoblastoma. While hepatoblastomas are predominantly sporadic, around 15% of cases develop as part of predisposition syndromes such...
5.
Schaeffer S, Gupta B, Calatayud A, Calderaro J, Caruso S, Hirsch T, et al.
J Hepatol
. 2023 May;
79(3):704-716.
PMID: 37201672
Background & Aims: Recurrent somatic mutations of the RPS6KA3 gene encoding for the serine/threonine kinase RSK2 were identified in hepatocellular carcinomas (HCCs), suggesting its tumour-suppressive function. Our goal was to...
6.
Ningarhari M, Caruso S, Hirsch T, Bayard Q, Franconi A, Vedie A, et al.
J Hepatol
. 2022 Feb;
76(5):1242-1243.
PMID: 35221117
No abstract available.
7.
Hirsch T, Pilet J, Morcrette G, Roehrig A, Monteiro B, Molina L, et al.
Cancer Discov
. 2021 Apr;
11(10):2524-2543.
PMID: 33893148
Pediatric liver cancers (PLC) comprise diverse diseases affecting infants, children, and adolescents. Despite overall good prognosis, PLCs display heterogeneous response to chemotherapy. Integrated genomic analysis of 126 pediatric liver tumors...
8.
Ningarhari M, Caruso S, Hirsch T, Bayard Q, Franconi A, Vedie A, et al.
J Hepatol
. 2020 Dec;
74(5):1155-1166.
PMID: 33338512
Background & Aims: Telomerase activation is the earliest event in hepatocellular carcinoma (HCC) development. Thus, we aimed to elucidate the role of telomere length maintenance during liver carcinogenesis. Methods: Telomere...
9.
Villemain L, Prigent S, Abou-Lovergne A, Pelletier L, Chiral M, Pontoglio M, et al.
Cancers (Basel)
. 2020 Aug;
12(8).
PMID: 32784704
Sigma receptor 1 (SigR1) is an endoplasmic reticulum resident integral membrane protein whose functions remain unclear. Although the liver shows the highest expression of SigR1, its role in this organ...
10.
Rebouissou S, Nault J
J Hepatol
. 2020 Jan;
72(2):215-229.
PMID: 31954487
Hepatocellular carcinoma (HCC) arises from hepatocytes through the sequential accumulation of multiple genomic and epigenomic alterations resulting from Darwinian selection. Genes from various signalling pathways such as telomere maintenance, Wnt/β-catenin,...